ARCHIVES

Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Calif. Stem Cell Group To Collaborate With Canadians.

June 20, 2008

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

Complete List of Recommendations by Centers Committee

October 18, 1996

Majority Of U.S. Cancer Patients Receive High-Quality Care, ASCO Study Finds

July 29, 2005

Yarbro Refuses To Seek Core Renewal, Quits Director Post

September 22, 1978